Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-12-04

Clinical Trial Update: Tafluprost Preservative Free Switch Study [Phase 4]

View source ↗

Summary

Phase 4 trial update on a tafluprost preservative-free switch study for glaucoma patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • tafluprost preservative free switch (tafluprost)

Snippet

Sponsor: Tun Hussein Onn National Eye Hospital | Conditions: Glaucoma, Primary Open Angle Glaucoma | Phase 4 | Status: COMPLETED